Xcout Intel
TrialSpark, Inc.
TrialSpark, Inc., which rebranded as Formation Bio, is a clinical-stage biotech and digital health company headquartered in New York, New York. Founded in 2016, the company builds technology platforms designed to optimize and accelerate critical aspects of clinical drug development.
Subscribe to see TrialSpark, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
TrialSpark, Inc. at a glance
TrialSpark, Inc. is a biotechnology company headquartered in United States. It has raised at least $528.2M across the 2 funding rounds on record. Its most recent funding round raised $372.2M in May 2024. Xcout tracks 9 named people at TrialSpark, Inc., including James Leslie (Chief Financial Officer).
TrialSpark, Inc. leadership
- James LeslieChief Financial Officer
- Dan NeilChief Technology Officer
- David SteinbergChief Business Officer
- Michael EhlersChief Scientific Officer & Head of R&D
- Sean ChildersGeneral Counsel
- Ben LiuCEO & Co-Founder
3 more named people on record for TrialSpark, Inc., with roles, board committees and tenure — see the full roster →
TrialSpark, Inc. funding rounds
At least $528.2M raised across the 2 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $372.2M | — | |
| — | $156M | 12 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
TrialSpark, Inc. competitors
A few of TrialSpark, Inc.'s closest competitors — see the full list of competitors and alternatives →
Formation Bio is a U.S.-based technology and drug-development company, formerly known as TrialSpark, that uses AI and software to help pharmaceutical companies develop medicines more efficiently. It serves biopharmaceutical partners by supporting clinical-trial operations and other parts of the drug-development process.
ProofPilot, Inc. provides a fully-integrated Software as a Service (SaaS) research platform aimed at transforming the current clinical trial model, located in New York.
Massive Bio is a digital health company that combines AI-powered technology with physician expertise to analyze medical conditions and match patients with clinical trials. While it has offices in Istanbul, it is headquartered in New York City.
RxSpark operates a prescription discount platform that allows users to compare local pharmacy prices, access coupons, and earn rewards.
Beaconcure Inc. is a biotechnology and software company that develops AI-enabled clinical trial data solutions. The company was founded in 2016 and is based in Tel Aviv, Israel, with an office in Boston, United States.
Spark Biopharma is headquartered in Seoul, South Korea, and focuses on discovering and providing small-molecule therapeutics using phenotypic discovery platforms to improve human health.
Get TrialSpark, Inc.'s news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Something wrong or missing about TrialSpark, Inc.? Suggest a correction
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on TrialSpark, Inc. in Xcout Intel
- 9 named people with titles, LinkedIn and board committees
- 2 funding rounds with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access